Effects of oral contraceptives and hormone replacement therapy on markers of cobalamin status.
Riedel
Bettina
B
Laboratory of Clinical Biochemistry, Section of Clinical Pharmacology, Haukeland University Hospital, Bergen, Norway. bettina.marie.riedel@helse-bergen.no
Bjørke Monsen
Anne-Lise
AL
Ueland
Per Magne
PM
Schneede
Jørn
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage*; D003430:Cross-Sectional Studies; D015914:Estrogen Replacement Therapy; D005260:Female; D006710:Homocysteine / Q000097:blood; D006801:Humans; D008764:Methylmalonic Acid / Q000097:blood; D008875:Middle Aged; D014155:Transcobalamins / Q000032:analysis; D014805:Vitamin B 12 / Q000097:blood*
D003277:Contraceptives, Oral, Combined; D014155:Transcobalamins; D006710:Homocysteine; D008764:Methylmalonic Acid; D014805:Vitamin B 12